Genmab A/S

Stocks

GMAB

DK0010272202

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 10/07/2026 pm IST			5-day change	1st Jan Change
1,868.50 ^DKK	-3.19%		0.00%	-7.82%

08/07	Nordic stocks in North America: Ericsson fell 0.7 percent	FW
07/07	Exchange-Traded Funds Lower, Equity Futures Mixed Amid Caution Over Chip Sector Outlook	MT

Transcript : Genmab A/S - Special Call

Published on 06/03/2024 at 07:30 pm IST

S&P Capital IQ

Add MarketScreener to your sources

Presentation Operator Message
Operator (Operator)

Hello, and welcome to Genmab's investor conference call to review data presented at ASCO from its mid- to late-stage pipeline. As a reminder, this call

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Genmab A/S

08/07	Nordic stocks in North America: Ericsson fell 0.7 percent	FW
07/07	Exchange-Traded Funds Lower, Equity Futures Mixed Amid Caution Over Chip Sector Outlook	MT
07/07	Wall Street's Chip Chill
07/07	Genmab Secures EU Approval for Drug Combination Intended for Relapsed or Refractory Follicular Lymphoma	MT
07/07	Genmab rebounds on a European Commission decision
07/07	Markets on Korean time
07/07	EU approves expanded use of Genmab's Tepkinly	FW
07/07	Genmab Wins EU Approval for Follicular Lymphoma Treatment Combination	MT
06/07	Genmab Announces Tepkinly in Combination with Lenalidomide and Rituximab Is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma	CI
06/07	BNP Paribas raises the target price for Genmab to 2,500 Danish kroner (2,400), reiterates outperform - BN	FW
03/07	Nordic stocks in North America, Ericsson fell 1.6%	FW
01/07	Nordic stocks in North America, AstraZeneca rose 1.3%	FW
01/07	Healthcare Stocks Fall as Markets Rotate Back to Tech -- Healthcare Roundup	DJ
30/06	AI stocks are ending the quarter with a shrug
30/06	With no catalyst, Europe nonetheless in the green